Analyses of factors involved in bone remodeling and inflammation in Ankylosing Spondylitis (AS) patients undergoing etanercept therapy

Trial Profile

Analyses of factors involved in bone remodeling and inflammation in Ankylosing Spondylitis (AS) patients undergoing etanercept therapy

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 26 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top